Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
Next revision Both sides next revision
covid:unpublished [2020/06/02 13:51]
biogridadmin
covid:unpublished [2020/07/02 16:14]
biogridadmin
Line 9: Line 9:
 |  **888800000001** ​ |  **[[https://​doi.org/​10.1101/​2020.03.22.002386|10.1101/​2020.03.22.002386]]** ​ |  Gordon DE (2020) ​ | **[[https://​thebiogrid.org/​220839/​publication|A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing]]** ​ | |  **888800000001** ​ |  **[[https://​doi.org/​10.1101/​2020.03.22.002386|10.1101/​2020.03.22.002386]]** ​ |  Gordon DE (2020) ​ | **[[https://​thebiogrid.org/​220839/​publication|A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing]]** ​ |
 |  **888800000002** ​ |  **[[https://​doi.org/​10.1101/​2020.03.29.20041962|10.1101/​2020.03.29.20041962]]** ​ |  Gao T (2020) ​ | **[[https://​thebiogrid.org/​221112/​publication|Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation]]** ​ | |  **888800000002** ​ |  **[[https://​doi.org/​10.1101/​2020.03.29.20041962|10.1101/​2020.03.29.20041962]]** ​ |  Gao T (2020) ​ | **[[https://​thebiogrid.org/​221112/​publication|Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation]]** ​ |
-|  **888800000003** ​ |  **[[https://​doi.org/​10.1101/​2020.02.16.951723|10.1101/​2020.02.16.951723]]** ​ |  ​Xie L (2020) ​ | **[[https://​thebiogrid.org/​221178/​publication|SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications on Neutralizing Antibody and Vaccine Development]]** ​ |+|  **888800000003** ​ |  **[[https://​doi.org/​10.1101/​2020.02.16.951723|10.1101/​2020.02.16.951723]]** ​ |  ​Sun C (2020) ​ | **[[https://​thebiogrid.org/​221178/​publication|SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications on Neutralizing Antibody and Vaccine Development]]** ​ |
 |  **888800000004** ​ |  **[[https://​doi.org/​10.1101/​2020.03.16.994236|10.1101/​2020.03.16.994236]]** ​ |  Procko E (2020) ​ | **[[https://​thebiogrid.org/​221182/​publication|The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2]]**  | |  **888800000004** ​ |  **[[https://​doi.org/​10.1101/​2020.03.16.994236|10.1101/​2020.03.16.994236]]** ​ |  Procko E (2020) ​ | **[[https://​thebiogrid.org/​221182/​publication|The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2]]**  |
 |  **888800000005** ​ |  **[[https://​doi.org/​10.1101/​2020.03.14.988345|10.1101/​2020.03.14.988345]]** ​ |  Wang K (2020) ​ | **[[https://​thebiogrid.org/​221183/​publication|SARS-CoV-2 invades host cells via a novel route: CD147-spike protein]]** ​ | |  **888800000005** ​ |  **[[https://​doi.org/​10.1101/​2020.03.14.988345|10.1101/​2020.03.14.988345]]** ​ |  Wang K (2020) ​ | **[[https://​thebiogrid.org/​221183/​publication|SARS-CoV-2 invades host cells via a novel route: CD147-spike protein]]** ​ |
Line 19: Line 19:
 |  **888800000012** ​ |  **[[https://​doi.org/​10.1101/​2020.03.31.019216|10.1101/​2020.03.31.019216]]** ​ |  Liang Q (2020) ​ | **[[https://​thebiogrid.org/​221199/​publication|Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis]]** ​ | |  **888800000012** ​ |  **[[https://​doi.org/​10.1101/​2020.03.31.019216|10.1101/​2020.03.31.019216]]** ​ |  Liang Q (2020) ​ | **[[https://​thebiogrid.org/​221199/​publication|Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis]]** ​ |
 |  **888800000013** ​ |  **[[https://​doi.org/​10.1101/​2020.04.15.042085|10.1101/​2020.04.15.042085]]** ​ |  Bestle D (2020) ​ | **[[https://​thebiogrid.org/​221402/​publication|TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets]]** ​ | |  **888800000013** ​ |  **[[https://​doi.org/​10.1101/​2020.04.15.042085|10.1101/​2020.04.15.042085]]** ​ |  Bestle D (2020) ​ | **[[https://​thebiogrid.org/​221402/​publication|TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets]]** ​ |
-|  **888800000014** ​ |  **[[https://​doi.org/​10.1101/​2020.04.09.033233|10.1101/​2020.04.09.033233]]** ​ |  Jin Z (2020) ​ | **[[https://​thebiogrid.org/​221403/​publication|Structural basis for the inhibition of COVID-19 virus main protease by carmofur, an antineoplastic drug]]** ​ | 
-|  **888800000015** ​ |  **[[https://​doi.org/​10.1101/​2020.04.08.032763|10.1101/​2020.04.08.032763]]** ​ |  Yin W (2020) ​ | **[[https://​thebiogrid.org/​221404/​publication|Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir]]** ​ | 
 |  **888800000016** ​ |  **[[https://​doi.org/​10.1101/​2020.04.14.042010|10.1101/​2020.04.14.042010]]** ​ |  Chi X (2020) ​ | **[[https://​thebiogrid.org/​221405/​publication|Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor Binding Domain]]** ​ | |  **888800000016** ​ |  **[[https://​doi.org/​10.1101/​2020.04.14.042010|10.1101/​2020.04.14.042010]]** ​ |  Chi X (2020) ​ | **[[https://​thebiogrid.org/​221405/​publication|Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor Binding Domain]]** ​ |
 |  **888800000017** ​ |  **[[https://​doi.org/​10.1101/​2020.04.06.20055475|10.1101/​2020.04.06.20055475]]** ​ |  Ye L (2020) ​ | **[[https://​thebiogrid.org/​221565/​publication|Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor]]** ​ | |  **888800000017** ​ |  **[[https://​doi.org/​10.1101/​2020.04.06.20055475|10.1101/​2020.04.06.20055475]]** ​ |  Ye L (2020) ​ | **[[https://​thebiogrid.org/​221565/​publication|Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor]]** ​ |
Line 30: Line 28:
 |  **888800000023** ​ |  **[[https://​doi.org/​10.1101/​2020.04.19.048710|10.1101/​2020.04.19.048710]]** ​ |  Zhao X (2020) ​ | **[[https://​thebiogrid.org/​221571/​publication|Broad and differential animal ACE2 receptor usage by SARS-CoV-2]]** ​ | |  **888800000023** ​ |  **[[https://​doi.org/​10.1101/​2020.04.19.048710|10.1101/​2020.04.19.048710]]** ​ |  Zhao X (2020) ​ | **[[https://​thebiogrid.org/​221571/​publication|Broad and differential animal ACE2 receptor usage by SARS-CoV-2]]** ​ |
 |  **888800000024** ​ |  **[[https://​doi.org/​10.1101/​2020.04.26.061705|10.1101/​2020.04.26.061705]]** ​ |  Viswanathan T (2020) ​ | **[[https://​thebiogrid.org/​221642/​publication|Structural Basis of RNA Cap Modification by SARS-CoV-2 Coronavirus]]** ​ | |  **888800000024** ​ |  **[[https://​doi.org/​10.1101/​2020.04.26.061705|10.1101/​2020.04.26.061705]]** ​ |  Viswanathan T (2020) ​ | **[[https://​thebiogrid.org/​221642/​publication|Structural Basis of RNA Cap Modification by SARS-CoV-2 Coronavirus]]** ​ |
-|  **888800000025** ​ |  **[[https://​doi.org/​10.1101/​2020.04.29.068890|10.1101/​2020.04.29.068890]]** ​ |  Rut W (2020) ​ | **[[https://​thebiogrid.org/​221777/​publication/activity-profiling-of-sars-cov-2-plpro-protease-provides-structural-framework-for-anti-covid-19-drug-design.html]]**  | +|  **888800000025** ​ |  **[[https://​doi.org/​10.1101/​2020.04.29.068890|10.1101/​2020.04.29.068890]]** ​ |  Rut W (2020) ​ | **[[https://​thebiogrid.org/​221777/​publication|Activity ​profiling of SARS-CoV-2-PLpro protease provides structural framework for anti-COVID-19 drug design]]** ​ | 
-|  **888800000026** ​ |  **[[https://​doi.org/​10.1101/​2020.04.27.063180|10.1101/​2020.04.27.063180]]** ​ |  Hillen HS (2020) ​ | **[[https://​thebiogrid.org/​221778/​publication/structure-of-replicating-sars-cov-2-polymerase.html]]**  | +|  **888800000026** ​ |  **[[https://​doi.org/​10.1101/​2020.04.27.063180|10.1101/​2020.04.27.063180]]** ​ |  Hillen HS (2020) ​ | **[[https://​thebiogrid.org/​221778/​publication|Structure ​of replicating ​SARS-CoV-2 polymerase]]** ​ | 
-|  **888800000027** ​ |  **[[https://​doi.org/​10.1101/​2020.04.29.068098|10.1101/​2020.04.29.068098]]** ​ |  Sun Z (2020) ​ | **[[https://​thebiogrid.org/​221779/​publication/mass-spectrometry-analysis-of-newly-emerging-coronavirus-hcov-19-spike-s-protein-and-human-ace2-reveals-camouflaging-glycans-and-unique-post-translational-modifications.html]]**  | +|  **888800000027** ​ |  **[[https://​doi.org/​10.1101/​2020.04.29.068098|10.1101/​2020.04.29.068098]]** ​ |  Sun Z (2020) ​ | **[[https://​thebiogrid.org/​221779/​publication|Mass spectrometry analysis of newly emerging coronavirus ​HCoV-19 spike protein and human ACE2 reveals camouflaging glycans and unique post-translational modifications]]** ​ | 
-|  **888800000028** ​ |  **[[https://​doi.org/​10.1101/​2020.05.03.073080|10.1101/​2020.05.03.073080]]** ​ |  Vuong W (2020) ​ | **[[https://​thebiogrid.org/​221830/​publication/feline-coronavirus-drug-inhibits-the-main-protease-of-sars-cov-2-and-blocks-virus-replication.html]]**  | +|  **888800000028** ​ |  **[[https://​doi.org/​10.1101/​2020.05.03.073080|10.1101/​2020.05.03.073080]]** ​ |  Vuong W (2020) ​ | **[[https://​thebiogrid.org/​221830/​publication|Feline ​coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication]]** ​ | 
-|  **888800000029** ​ |  **[[https://​doi.org/​10.1101/​2020.05.02.20086876|10.1101/​2020.05.02.20086876]]** ​ |  Zhang D (2020) ​ | **[[https://​thebiogrid.org/​221831/​publication/ultra-fast-and-onsite-interrogation-of-severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2-in-environmental-specimens-via-surface-enhanced-raman-scattering-sers.html]]**  | +|  **888800000029** ​ |  **[[https://​doi.org/​10.1101/​2020.05.02.20086876|10.1101/​2020.05.02.20086876]]** ​ |  Zhang D (2020) ​ | **[[https://​thebiogrid.org/​221831/​publication|Ultra-fast and onsite interrogation of Severe Acute Respiratory Syndrome Coronavirus ​(SARS-CoV-2in environmental specimens via surface enhanced ​Raman scattering ​(SERS)]]**  | 
-|  **888800000030** ​ |  **[[https://​doi.org/​10.1101/​2020.05.05.079202|10.1101/​2020.05.05.079202]]** ​ |  Huo J (2020) ​ | **[[https://​thebiogrid.org/​221832/​publication/​neutralization-of-sars-cov-2-by-destruction-of-the-prefusion-spike.html]]**  | +|  **888800000030** ​ |  **[[https://​doi.org/​10.1101/​2020.05.05.079202|10.1101/​2020.05.05.079202]]** ​ |  Huo J (2020) ​ | **[[https://​thebiogrid.org/​221832/​publication|Neutralization ​of SARS-CoV-2 by destruction of the prefusion ​Spike]]**  | 
-|  **888800000031** ​ |  **[[https://​doi.org/​10.1101/​2020.05.06.079830|10.1101/​2020.05.06.079830]]** ​ |  Zha L (2020) ​ | **[[https://​thebiogrid.org/​221833/​publication/​development-of-a-covid-19-vaccine-based-on-the-receptor-binding-domain-displayed-on-virus-like-particles.html]]**  | +|  **888800000031** ​ |  **[[https://​doi.org/​10.1101/​2020.05.06.079830|10.1101/​2020.05.06.079830]]** ​ |  Zha L (2020) ​ | **[[https://​thebiogrid.org/​221833/​publication|Development ​of a COVID-19 vaccine based on the receptor binding domain displayed on virus-like particles]]** ​ | 
-|  **888800000032** ​ |  **[[https://​doi.org/​10.1101/​2020.05.02.043554|10.1101/​2020.05.02.043554]]** ​ |  Gunther S (2020) ​ | **[[https://​thebiogrid.org/​221835/​publication/catalytic-cleavage-of-heat-and-subsequent-covalent-binding-of-the-tetralone-moiety-by-the-sars-cov-2-main-protease.html]]**  | +|  **888800000032** ​ |  **[[https://​doi.org/​10.1101/​2020.05.02.043554|10.1101/​2020.05.02.043554]]** ​ |  Gunther S (2020) ​ | **[[https://​thebiogrid.org/​221835/​publication|Catalytic ​cleavage of HEAT and subsequent covalent binding of the tetralone moiety by the SARS-CoV-2 main protease]]** ​ | 
-|  **888800000033** ​ |  **[[https://​doi.org/​10.1101/​2020.05.01.20077743|10.1101/​2020.05.01.20077743]]** ​ |  Wu Y (2020) ​ | **[[https://​thebiogrid.org/​221836/​publication/a-non-competing-pair-of-human-neutralizing-antibodies-block-covid-19-virus-binding-to-its-receptor-ace2.html]]**  | +|  **888800000033** ​ |  **[[https://​doi.org/​10.1101/​2020.05.01.20077743|10.1101/​2020.05.01.20077743]]** ​ |  Wu Y (2020) ​ | **[[https://​thebiogrid.org/​221836/​publication|A non-competing pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ​ACE2]]**  | 
-|  **888800000034** ​ |  **[[https://​doi.org/​10.1101/​2020.05.03.074914|10.1101/​2020.05.03.074914]]** ​ |  Liu X (2020) ​ | **[[https://​thebiogrid.org/​221959/​publication/​neutralizing-antibodies-isolated-by-a-site-directed-screening-have-potent-protection-on-sars-cov-2-infection.html]]**  |+|  **888800000034** ​ |  **[[https://​doi.org/​10.1101/​2020.05.03.074914|10.1101/​2020.05.03.074914]]** ​ |  Liu X (2020) ​ | **[[https://​thebiogrid.org/​221959/​publication|Neutralizing Antibodies Isolated ​by a site-directed ​Screening ​have Potent Protection ​on SARS-CoV-2 Infection]]**  |
 
covid/unpublished.txt · Last modified: 2020/08/05 13:15 by biogridadmin